Analyst Consensus ?
ConsensusBuy34 ratings
Bullish2573.5%
Neutral823.5%
Bearish13.0%
FN2 Earnings Intelligence
International Flavors & Fragrances Inc. analyst ratings
International Flavors & Fragrances Inc. (IFF) analyst consensus, price targets, and firm-level rating history from FN2 Research.
Analyst 52W Price Targets
$90.81Current
$67Low
$100.28Average
$170High
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Oct 29, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| Oppenheimer | Outperform | Outperform | Maintain | Oct 22, 2026 |
| Barclays | Overweight | Overweight | Maintain | Oct 16, 2026 |
| Citigroup | Buy | Buy | Maintain | Oct 7, 2026 |
| Argus Research | Buy | Buy | Maintain | Oct 7, 2026 |
| UBS | Neutral | Neutral | Maintain | Aug 6, 2026 |
| Benchmark | Buy | Buy | Maintain | Aug 6, 2026 |
| Morgan Stanley | Overweight | Overweight | Maintain | Jul 1, 2026 |
| JP Morgan | Overweight | Overweight | Maintain | May 7, 2026 |
| Mizuho | Outperform | Outperform | Maintain | Feb 17, 2026 |
| Wells Fargo | Overweight | Overweight | Maintain | Feb 13, 2026 |
| B of A Securities | Buy | Buy | Maintain | Oct 14, 2025 |
| Wolfe Research | Peer Perform | Underperform | Upgrade | Sep 8, 2025 |
| Tigress Financial | Buy | Buy | Maintain | Aug 26, 2025 |
| Baird | Outperform | Outperform | Maintain | May 8, 2025 |
| Stifel | Buy | Buy | Maintain | Apr 10, 2025 |
| Vertical Research | Buy | Hold | Upgrade | Nov 7, 2024 |
| Deutsche Bank | Buy | Buy | Maintain | Mar 20, 2024 |
| Jefferies | Buy | Hold | Upgrade | Jan 12, 2024 |
| Goldman Sachs | Neutral | Neutral | Maintain | Aug 10, 2023 |
| Credit Suisse | Outperform | Outperform | Maintain | Aug 8, 2023 |
| Societe Generale | Buy | Buy | Maintain | Nov 9, 2022 |
| Berenberg | Hold | Buy | Downgrade | Aug 24, 2022 |
| Exane BNP Paribas | Neutral | Underperform | Upgrade | Jan 12, 2021 |
| Stephens & Co. | Overweight | Overweight | Maintain | Jul 10, 2020 |
| CFRA | Buy | Buy | Maintain | May 13, 2020 |
| Stifel Nicolaus | Hold | Hold | Maintain | Dec 16, 2019 |
| Citi | Buy | Neutral | Upgrade | Nov 22, 2019 |
| KeyBanc | Overweight | Overweight | Maintain | Aug 8, 2019 |
| Raymond James | Underperform | Market Perform | Downgrade | Nov 16, 2018 |
| Argus | Hold | Buy | Downgrade | Jun 8, 2018 |
| Evercore ISI Group | Outperform | In Line | Upgrade | Jan 17, 2018 |
| Gabelli & Co. | Hold | Buy | Downgrade | Aug 10, 2016 |
| Edward Jones | Buy | Buy | Maintain | Oct 1, 2015 |
| Janney Capital | Buy | Buy | Maintain | Nov 25, 2013 |
Named analyst price targets
Upside is calculated against the persisted current price $90.81. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Oppenheimer | Kristen Owen | $108 | $91.76 | +18.9% | Oct 22, 2026 |
| Barclays | Analyst unavailable | $105 | $90.29 | +15.6% | Oct 16, 2026 |
| Argus Research | Analyst unavailable | $95 | $84.2 | +4.6% | Oct 7, 2026 |
| Barclays | Analyst unavailable | $96 | $84.55 | +5.7% | Aug 7, 2026 |
| Robert W. Baird | Ghansham Panjabi | $100 | $85.61 | +10.1% | Aug 6, 2026 |
| UBS | Joshua Spector | $91 | $85.92 | +0.2% | Aug 6, 2026 |
| Oppenheimer | Analyst unavailable | $95 | $85.87 | +4.6% | Aug 6, 2026 |
| Vertical Research | Analyst unavailable | $93 | $85.63 | +2.4% | Aug 6, 2026 |
| Morgan Stanley | Analyst unavailable | $95 | $80.02 | +4.6% | Jul 1, 2026 |
| Oppenheimer | Analyst unavailable | $90 | $82.93 | -0.9% | May 7, 2026 |
| Barclays | Lauren Lieberman | $90 | $82.93 | -0.9% | May 7, 2026 |
| Barclays | Lauren Lieberman | $80 | $72.1 | -11.9% | Apr 14, 2026 |
| UBS | Joshua Spector | $75 | $73.13 | -17.4% | Apr 9, 2026 |
| Deutsche Bank | Analyst unavailable | $95 | $82.18 | +4.6% | Feb 17, 2026 |
| Mizuho Securities | Analyst unavailable | $92 | $83 | +1.3% | Feb 17, 2026 |
| Morgan Stanley | Lisa De Neve | $93 | $82.43 | +2.4% | Feb 13, 2026 |
| Robert W. Baird | Analyst unavailable | $90 | $82.44 | -0.9% | Feb 13, 2026 |
| UBS | Joshua Spector | $85 | $81.72 | -6.4% | Feb 13, 2026 |
| Oppenheimer | Analyst unavailable | $97 | $81.14 | +6.8% | Feb 13, 2026 |
| Barclays | Analyst unavailable | $91 | $81.5 | +0.2% | Feb 13, 2026 |
| Mizuho Securities | John Roberts | $85 | $76.97 | -6.4% | Feb 12, 2026 |
| Argus Research | Analyst unavailable | $80 | $72.78 | -11.9% | Jan 22, 2026 |
| Barclays | Lauren Lieberman | $78 | $70.78 | -14.1% | Jan 16, 2026 |
| UBS | Analyst unavailable | $71 | $69.23 | -21.8% | Jan 12, 2026 |
| UBS | Joshua Spector | $66 | $61.6 | -27.3% | Oct 6, 2025 |
| Mizuho Securities | Analyst unavailable | $75 | $61.51 | -17.4% | Oct 3, 2025 |
| Oppenheimer | Kristen Owen | $89 | $64.23 | -2.0% | Aug 7, 2025 |
| Barclays | Lauren Lieberman | $82 | $78.18 | -9.7% | Mar 27, 2025 |
| Argus Research | Alexandra Yates | $93 | $82.56 | +2.4% | Jan 7, 2025 |
| Morgan Stanley | Lisa De Neve | $110 | $91.21 | +21.1% | Nov 11, 2024 |
| Stifel Nicolaus | Mark Astachan | $121 | $103.88 | +33.2% | Oct 24, 2024 |
| Oppenheimer | Kristen Owen | $117 | $101.28 | +28.8% | Sep 11, 2024 |
| Mizuho Securities | John Roberts | $120 | $103.99 | +32.1% | Sep 3, 2024 |
| Stifel Nicolaus | Mark Astrachan | $115 | $95.67 | +26.6% | Jul 22, 2024 |
| UBS | Joshua Spector | $100 | $96.64 | +10.1% | Jul 9, 2024 |
| Jefferies | Laurence Alexander | $111 | $98.14 | +22.2% | Jun 24, 2024 |
| Oppenheimer | Kristen Owen | $116 | $97.9 | +27.7% | Jun 6, 2024 |
| Morgan Stanley | Lisa De Neve | $100 | $98.1 | +10.1% | May 21, 2024 |
| Jefferies | Laurence Alexander | $110 | $97.23 | +21.1% | May 8, 2024 |
| Mizuho Securities | John Roberts | $98 | $88.66 | +7.9% | May 7, 2024 |
| Barclays | Lauren Lieberman | $75 | $86.57 | -17.4% | Apr 12, 2024 |
| Wells Fargo | Michael Sison | $100 | $85.5 | +10.1% | Apr 4, 2024 |
| Deutsche Bank | David Begleiter | $100 | $83.92 | +10.1% | Mar 20, 2024 |
| Stifel Nicolaus | Mark Astachan | $85 | $83.05 | -6.4% | Mar 19, 2024 |
| Morgan Stanley | Lisa De Neve | $90 | $79.76 | -0.9% | Jan 22, 2024 |
| Jefferies | Laurence Alexander | $112 | $80.25 | +23.3% | Jan 12, 2024 |
| J.P. Morgan | Jeffrey Zekauskas | $67 | $80.97 | -26.2% | Jan 2, 2024 |
| Argus Research | John Eade | $85 | $75.67 | -6.4% | Nov 28, 2023 |
| Stifel Nicolaus | Mark Astrachan | $81 | $68.09 | -10.8% | Sep 18, 2023 |
| Stifel Nicolaus | Mark Astrachan | $160 | $133.19 | +76.2% | Jan 25, 2022 |
| Jefferies | Laurence Alexander | $180 | $144.97 | +98.2% | Jan 13, 2022 |
| Citigroup | PJ Juvekar | $147 | $136.21 | +61.9% | May 20, 2021 |
| Societe Generale | Thomas Swoboda | $170 | $138.69 | +87.2% | May 19, 2021 |
| Morgan Stanley | Lisa De Neve | $160 | $137.3 | +76.2% | Apr 12, 2021 |
Track every rating change on IFF the moment it posts. Free to start.
Start freeGet the IFF recap when the next report posts
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.